| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 58.446 | 66.890 | 60.928 | 81.230 | 67.152 | 60.401 | 64.238 | 69.547 | 78.470 | 90.103 |
| Total Income - EUR | 62.748 | 67.751 | 61.482 | 81.560 | 70.053 | 61.896 | 64.398 | 71.067 | 83.515 | 97.961 |
| Total Expenses - EUR | 12.153 | 15.334 | 18.879 | 21.379 | 18.964 | 18.133 | 24.613 | 28.203 | 27.776 | 31.167 |
| Gross Profit/Loss - EUR | 50.595 | 52.418 | 42.604 | 60.182 | 51.089 | 43.763 | 39.785 | 42.864 | 55.739 | 66.794 |
| Net Profit/Loss - EUR | 48.714 | 50.387 | 40.762 | 59.366 | 50.411 | 43.188 | 39.154 | 42.167 | 55.018 | 63.914 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Toya - Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.008 | 369 |
| Current Assets | 58.261 | 77.299 | 94.780 | 124.259 | 141.207 | 172.406 | 193.174 | 225.086 | 267.051 | 314.400 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 38 | 0 | 0 | 0 |
| Receivables | 11.529 | 19.178 | 27.361 | 37.066 | 48.676 | 38.311 | 23.932 | 28.062 | 21.407 | 16.481 |
| Cash | 46.732 | 58.121 | 67.419 | 87.192 | 92.531 | 134.095 | 169.204 | 197.024 | 245.644 | 297.919 |
| Shareholders Funds | 48.768 | 50.440 | 40.814 | 59.418 | 50.461 | 43.238 | 39.202 | 42.216 | 97.106 | 63.962 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 9.493 | 26.859 | 53.966 | 64.841 | 90.746 | 129.168 | 153.972 | 182.870 | 172.001 | 250.808 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Toya - Med Srl